You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 16, April 23/30, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Psychiatry
 •Obesity
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Antipsychotic-Induced Weight Gain in Patients With Schizophrenia

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In the report of their randomized controlled trial, Dr Wu and colleagues1 concluded that lifestyle intervention and metformin alone and in combination demonstrated efficacy for weight reduction in patients taking antipsychotic medications. The rationale for their study was based on the assumption that weight loss in this population is beneficial to health and that the "induction of obesity by antipsychotic agents" is linked with greater morbidity and mortality.

However, in this study the majority of participants were not obese or even overweight by conventional body mass index (BMI) cut points, and the generalizability of the findings to overweight or obese populations is unclear. Given that there may be ethnic differences in what is considered to be a normal or healthy BMI, the authors could have argued that the treatment groups were overweight relative to a lower cut point that is appropriate to the Chinese population. However, Gu . . . [Full Text of this Article]

David J. Llewellyn, PhD
dl355@medschl.cam.ac.uk

Felix Naughton, MSc
Department of Public Health and Primary Care
University of Cambridge
Cambridge, United Kingdom



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLES

Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain: A Randomized Controlled Trial
Ren-Rong Wu, Jing-Ping Zhao, Hua Jin, Ping Shao, Mao-Sheng Fang, Xiao-Feng Guo, Yi-Qun He, Yi-Jun Liu, Jin-Dong Chen, and Le-Hua Li
JAMA. 2008;299(2):185-193.
ABSTRACT | FULL TEXT  

Body Weight and Mortality Among Men and Women in China
Dongfeng Gu, Jiang He, Xiufeng Duan, Kristi Reynolds, Xigui Wu, Jing Chen, Guangyong Huang, Chung-Shiuan Chen, and Paul K. Whelton
JAMA. 2006;295(7):776-783.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Antipsychotic-Induced Weight Gain in Patients With Schizophrenia
Ganesan Venkatasubramanian
JAMA. 2008;299(16):1899.
EXTRACT | FULL TEXT  

Antipsychotic-Induced Weight Gain in Patients With Schizophrenia—Reply
Jing-Ping Zhao
JAMA. 2008;299(16):1899-1900.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.